RICHMOND, Va., April 29, 2002 (PRIMEZONE) -- Biotech and Genomics sector companies including Genaera Corporation (Nasdaq:GENR), Gene Logic, Inc. (Nasdaq:GLGC), and Orchid BioSciences, Inc. (Nasdaq:ORCH) will be speaking directly to investors at a Forum to be held on May 11. Other presenters include GenVec, Genaissance Pharmaceuticals, Inc., and keynote speaker Dennis E. Ohman of the Microbiology & Immunology Department at the Medical College of Virginia Campus of Virginia Commonwealth University. The event is open to the public and will take place at the Sheraton Suites in Alexandria, Virginia. By attending this Forum, onsite or online at www.informedinvestors.com, investors can hear directly from company executives and get their investment information straight from the source.
Executives from each company will give 20-minute analyst-style presentations, and a 5-10 minute question and answer session with the investor audience follows each presentation. The event, produced by Informed Investors, will take place from 8:00 a.m. to 12:00 p.m. ET. All presentations will be archived on the Internet at www.informedinvestors.com, www.vcall.com, and www.investorconference.com.
Information and registration are available at www.informedinvestors.com or by calling 888-301-6618.
Dale Pfost, Ph.D., chairman, president and chief executive officer of Orchid BioSciences, Inc., will talk to investors at 9:15 a.m. ET. Orchid BioSciences' business units are leading providers of products, services and technologies for value-added genotyping. Orchid's proprietary SNP scoring technology, SNP-IT(tm), powers the SNPstream(r) instruments, SNPware(tm) consumables and high throughput SNP scoring services sold by Orchid Life Sciences to pharmaceutical, biotechnology, agricultural and academic customers. The versatility of SNP-IT has enabled Orchid to partner with industry leaders to make SNP-IT-enabled products available on a wide variety of instrument platforms as part of Orchid's Platform Propagation(tm) strategy. Orchid provides identity genomics testing for paternity and forensics through Orchid GeneScreen and Orchid Cellmark. Orchid Diagnostics markets products and services for HLA genotyping, disease susceptibility testing and immunogenetics, and Orchid GeneShield is developing programs designed to accelerate the adoption of personalized medicine. More information on Orchid can be found at its Web site www.orchid.com.
Genaera Corporation is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. Its research and development efforts are focused on anti-angiogenesis, obesity, infectious diseases and respiratory diseases. They will be presenting at 10:30.
Robert G. Burrows, Director, Corporate Communications for Gene Logic will be presenting at 11:00 a.m. EST. Gene Logic Inc. is a leading provider of genomic information and bioinformatics products related to gene activity in human disease and toxicity to reduce the time, risk and cost of global pharmaceutical, biotechnology and life science drug discovery and development.
Informed Investors is the leading producer of online and offline industry-specific investment conferences for individual investors and a member of the WILink family of companies serving self-reliant investors.
About WILink: Since 1992, WILink (www.wilink.com) has opened information channels between public companies and potential investors. WILink is an investor relations and investment services group that markets a range of services that help publicly traded companies and mutual funds attract and retain well informed investors, while providing investors with access to information to make well informed investment decisions. This year WILink will make more than 7 million investor introductions to over 4,200 corporate clients through services including The Annual Reports Service, The Fund Info Service, Vcall (www.vcall.com) Investor Conference (www.investorconference.com) and Informed Investors Forums (www.informedinvestors.com). These services provide investors free access to onsite and webcast investor events and company financial reports through WILink's relationships with over 220 leading financial media channels in 14 countries including The Wall Street Journal, Financial Times, Barron's and Yahoo! Finance. For companies and mutual funds, these services enable compliance with regulation fair-disclosure requirements and provide visibility with investors at the precise point investors are making decisions. WILink, Inc. a wholly owned subsidiary of WILink.com plc (WLK on The London Stock Exchange) began operations in Richmond, Va. in 1993.